NICORETTE
Generic: NICOTINE POLACRILEX
Haleon US Holdings LLCManufacturer
ORALRoute
NICOTINEActive Substance
2009-05-18Original Approval
NICORETTE is FDA application NDA022360, sponsored by HALEON US HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2014-02-20
Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. LabeFailed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class III2014-02-20
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class III2014-02-20
Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons. OTC. LabeFailed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class III2014-02-20
Nicorette (nicotine polacrilex) Lozenges Mini, 2 mg, Original Flavor, 20 Lozenge, 27 Lozenge, 81 Lozenge and 135 LozengeFailed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Top Reported Reactions
1
DRUG INEFFECTIVE
4,772 reports
2
NICOTINE DEPENDENCE
4,064 reports
3
INTENTIONAL DRUG MISUSE
3,435 reports
4
NAUSEA
2,817 reports
5
MALAISE
1,480 reports
6
HEADACHE
1,255 reports
7
DIZZINESS
1,244 reports
8
DRUG ADMINISTRATION ERROR
1,176 reports
9
OVERDOSE
1,129 reports
10
VOMITING
1,050 reports